AVCRF (Avricore Health) ROE % Adjusted to Book Value: -6.16% (As of Mar. 2026)


What is Avricore Health ROE % Adjusted to Book Value?

Avricore Health AVCRF +19.18% ROE % Adjusted to Book Value is -6.16% as of Mar. 2026. The stock has 6 warning signs investors should review.

Avricore Health's ROE % for the quarter that ended in Mar. 2026 was -280.47%. Avricore Health's PB Ratio for the quarter that ended in Mar. 2026 was 45.55. Avricore Health's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -6.16%.

Avricore Health ROE % Adjusted to Book Value Related Terms

Avricore Health ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Avricore Health's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avricore Health ROE % Adjusted to Book Value Chart

Avricore Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -33.46 -2.54 -4.85 -11.03 -10.18

Avricore Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.07 -44.18 -20.11 -28.22 -6.16

AVCRF vs TMO, DHR, IDXX: ROE % Adjusted to Book Value Comparison

For the Diagnostics & Research subindustry, Avricore Health's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avricore Health ROE % Adjusted to Book Value vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Avricore Health's ROE % Adjusted to Book Value falls into.


Avricore Health ROE % Adjusted to Book Value Calculation

Avricore Health's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-162.02% / 15.92
=-10.18%

Avricore Health's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-280.47% / 45.55
=-6.16%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -6.16% mean?
Avricore Health (AVCRF) has a ROE % Adjusted to Book Value of -6.16% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Avricore Health and its competitors.
Is Avricore Health's ROE % Adjusted to Book Value too high?
Avricore Health's current ROE % Adjusted to Book Value is -6.16%.
How does Avricore Health's ROE % Adjusted to Book Value compare to TMO and DHR?
Avricore Health's ROE % Adjusted to Book Value of -6.16% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Diagnostics & Research company?
A good ROE % Adjusted to Book Value depends on the Medical Diagnostics & Research industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Avricore Health and its competitors. Avricore Health's current ROE % Adjusted to Book Value is -6.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avricore Health stock overvalued right now?
Based on GuruFocus' analysis, Avricore Health (AVCRF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.02, compared to a current price of $0.04 — trading 95.9% above its estimated fair value. The current ROE % Adjusted to Book Value is -6.16%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Avricore Health (AVCRF), the current ROE % Adjusted to Book Value is -6.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avricore Health Business Description

Other Exchanges AVCR:Canada
Address 1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The company has only one segment, being the HealthTab - Point of Care Business in Canada. The company's revenues are generated from operating leases of the POCT system and the sale of testing panels. Geographically, the company operates in Canada and United Kingdom, it derives maximum revenue Canada.